Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

MabVax Therapeutics Holdings Inc


Ticker Change

Company Profile for MabVax Therapeutics Holdings Inc (TELK)

MabVax Therapeutics Holdings Inc. is a biopharmaceutical company that discovers, develops, and commercializes small molecule drugs to treat serious diseases. The Company's most advanced product development programs are for the treatment of cancer and diabetes.

Contact Information

MabVax Therapeutics Holdings Inc

11588 Sorrento Valley Road
Suite 20
San Diego, CA 92121
United States
Phone: 1-858-259-9405
Fax: 1-650-845-7800

Key Executives for MabVax Therapeutics Holdings Inc (TELK)

J David HansenPresident/CEO/Co-FounderGregory P HansonChief Financial Officer
Philip O LivingstonChief Science OfficerWolfgang W ScholzVP:Antibody Discovery
Paul W MaffuidVP:Pharmaceutical Dev & Ops

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil